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Background. In contrast to the benefits of intensive insulin therapy (IIT) in the surgical intensive care
unit (SICU), its benefits in the burn ICU (BICU) remain unclear. Furthermore, IIT and tight glycemic
control has received little attention in elderly ICU patients.
Methods. We evaluated the normalization of blood glucose level with IIT in BICU and SICU patients.
From October 2006 to July 2007, 970 patients were admitted to our BICU and our SICU. A total of 79
of these patients met criteria for initiation of IIT, 37 of who required IIT for at least 72 hours. Data were
analyzed to determine if tight glycemic control (blood glucose #150 mg/dL by day 3) is associated with
reduced morbidity and mortality.
Results. Tight control was better achieved in SICU patients (45%) than in BICU patients (33%). Daily
insulin requirements were approximately 2-fold greater in SICU patients compared with BICU patients
(P < .05). Tight control in both SICU and BICU patients was associated with a decreased incidence of
sepsis compared with poor glycemic control (10% vs 58% and 60% vs 70%, respectively) and a de-
creased mortality rate (0 vs 58% and 20% vs 50%; SICU vs BICU, respectively). The percentage of
total body surface area burned in BICU patients was 10% and 45% in the #150 and >150 mg/dL
groups. Mortality rate in the poor control group was >10-fold greater than that of the tight control group;
for patients $65 years of age, mortality was nearly double than that of patients <65 years of age. The
greatest mortality rate (62%) was seen in patients >65 years of age with poor control.
Conclusion. Tight control with IIT is associated with an increased survival rate in both BICU and SICU
patients. Age is associated with survival, with patients older than 65 years of age having the greatest
mortality rate. (Surgery 2009;146:922-30.)
From the Departments of Surgery and Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MDINTENSIVE TREATMENT OF HYPERGLYCEMIA in critically ill
patients has substantial positive outcomes.1-3 In
2001, Van den Berghe et al1 showed that mainte-
nance of euglycemia with intensive insulin therapy
(IIT) in a mixed-service surgical intensive care unit
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doi:10.1016/j.surg.2009.04.03522 SURGERY(SICU) was associated with reduced mortality, mor-
bidity, and duration of stay in critically ill surgical
patients, largely due to a striking reduction in
infection.1
Currently, the use of IIT to achieve tight
glycemic control is becoming a standard practice
in many medical facilities. However, achievement
of tight glycemic control to levels reported by Van
den Berghe1 is extremely difficult and costly (both
physiologically and monetarily), and seldom
achieved. In fact, a recent metaanalysis4 reports
that Van den Berghe et al’s study is an outlier. Nev-
ertheless, it is still not clear whether tight control
should be the goal and whether, or to what degree,
it is beneficial.5
Most recently, the results of the Normoglycaemia
in Intensive Care Evaluation and Survival Using
Glucose Algorithm Regulation (NICE-SUGAR)
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reported that, in an intensive glucose control group
(target level: range, 81--108 mg/dL), mortality
among patients in the intensive care unit (ICU) was
increased compared to a conventional glucose con-
trol group (target level,#180 mg/dL). In the inten-
sive glucose control group, severe hypoglycemia
(blood glucose #40 mg/dl) occurred in 6.8% of
the patients and only 0.5% of the patients in the con-
ventional control group.
The American Diabetes Association and the
American Association of Clinical Endocrinologist
responded to this report by suggesting that, until
more data are available, it is prudent to treat
critically ill patients less intensively rather than
attempt to achieve blood glucose levels in the
range of 80 to 108 mg/dL.7 Similarly, in response
to the NICE-SUGAR report, the Endocrine Society
has suggested that the target value in the ICU
should be between 144 and 180 mg/dL.8
In October 2006, the Johns Hopkins Bayview
Medical Center Surgical and Burn Intensive Care
Units (SICU and BICU) instituted an intensive
insulin infusion protocol (IIT) based upon the
Yale protocol.3 Since that time, the IIT protocol
has been used in hyperglycemic critically ill adult
patients in the mixed-service surgical intensive
care unit (SICU) and burn intensive care unit
(BICU) with an anticipated duration of stay
greater than 24 hours. The protocol involves the
use of continuous intravenous (IV) insulin accom-
panied by hourly monitoring until blood glucose
levels and insulin demand have stabilized. As a
part of the protocol, glucose levels and insulin ti-
tration are reviewed for each patient to assess the
protocol’s effectiveness.
Although the benefit of tight glycemic control
obtained by IIT has been demonstrated in the SICU
population,1-3 the benefit of IIT in the BICUpatient
population remains unclear. The response to burn
injury is similar to the hyperglycemic stress response
induced by severe trauma, but is greater in severity
and duration9 and directly proportional to the total
body surface area (TBSA) burned.10 This hypergly-
cemic response to burns has been shown to be asso-
ciated with worsened clinical outcomes.11 Whereas
insulin therapy may help control the hyperglycemia
associated with burn injury, insulin also promotes
muscle anabolism and attenuates the systemic in-
flammatory response.12,13 Therefore, there may be
reason to believe that the burned ICU patient could
benefit more from IIT than the SICU patient; how-
ever, to our knowledge, the outcome benefits associ-
ated with IIT in the adult BICUpopulation have not
been examined.Increased age has also been shown to be asso-
ciated with decreased survival in critically ill and
injured patients, but the contributions of diabetes
or glucose intolerance to this association have not
been well studied.14 Similarly, the efficacy of IIT in
elderly SICU or BICU patients is unknown.
Our goal was to determine, through the use of a
prospective cohort study, whether critically ill burn
patients benefit from tight glycemic control
achieved by IIT in a manner analogous to the
benefits already documented in SICU patients,
such as decreasing overall rates of sepsis and
mortality. We also sought to determine whether
the benefit of tight glycemic control with IIT is as-
sociated with a similar degree of risk of hypoglyce-
mia in both BICU and SICU patients. Finally, we
sought to examine whether the benefits of IIT
are as pronounced in elderly patients as they are
in younger patients.
METHODS
Study population. This study was approved by
the Johns Hopkins Medicine Institutional Review
Board. All patients admitted to the Johns Hopkins
Bayview Medical Center SICU or BICU were eval-
uated for study inclusion. The IIT protocol had 3
entry criteria: (1) an adult patient with morbidity
significant enough to warrant designation as a crit-
ically ill patient; (2) blood glucose level greater
than 119 mg/dL; and (3) an anticipated duration
of ICU stay greater than 24 hours. The IIT proto-
col was approved by the Pharmacy and Therapeu-
tics Committee before its 2006 implementation in
the mixed-service SICU and BICU. The protocol
was implemented after a period of training for staff
in both units, and was accompanied by ongoing su-
pervision and assessment by an oversight commit-
tee with representatives of the nursing and
physician staff of both units.
To evaluate the effect of tight glycemic control,
we divided subjects into those whose mean blood
glucose measurement on day 3 of the IIT was
<150 mg/dL (tight control) and $150 mg/dL
(poor control). To evaluate the effect of IIT on
age, subjects were divided into 2 groups: younger
(age <65 years) and older (age $65 years).
Study design. The Johns Hopkins Bayview Med-
ical Center IIT protocol requires that the patient’s
blood glucose be measured at least hourly until 3
consecutive glucose values are within target glu-
cose range of 90--120 mg/dL without requiring a
change in the insulin infusion. The frequency of
blood glucose determinations is dependent upon
the patient’s blood glucose stability, current clini-
cal condition, and nutritional intake.
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insulin (Humulin R; Eli Lilly and Company,
Indianapolis, IN), a recombinant DNA human
insulin. Adjustments to the insulin infusion were
made depending upon blood glucose values ob-
tained from point of service (finger sticks), from
scheduled venous sample laboratory values, and/
or from arterial blood samples obtained from an
indwelling catheter. The precise amount of IV
insulin was determined by the algorithm in the
Yale insulin infusion protocol,3 as calculated by the
ICU staff, and was recorded in the patient medical
record. To assess the effect of successful glycemic
control, an average blood glucose value #150
mg/dL on day 3 was used to define tight glycemic
control and an average blood glucose value >150
mg/dL was used to define poor glycemic control
as described previously.15 The data from all pa-
tients who remained on the IIT for at least 72
hours were selected for analysis.
Data collection. Clinical and demographic in-
formation, such as diagnosis and outcome, for
both SICU and BICU patients were entered into a
prospectively collected secure database. Blood glu-
cose values were recorded (point of service, lab
blood glucose, and arterial blood from an indwell-
ing catheter), and total daily IV insulin units (U)
administered (U/h*h, insulin rate*hour) was
recorded.
For both SICU and BICU patients, variables that
have a known impact on blood glucose levels were
recorded. These variables included specific medi-
cations (eg, cortisol, glucagon, 50% dextrose, and
vasopressors), volume and quality of nutritional
feeding, operative or interventional procedures,
and incidence of sepsis or infection. For patients in
the BICU, the etiology of burn injury and the
percentage of TBSA were also noted. The primary
outcomes recorded were incidences of sepsis, hos-
pital deaths (in the ICU or when transferred to the
surgical floor), and hypoglycemic events (<60 mg/
dL). Duration of hospital stay was also noted for
each patient.
Statistical analysis. The trapezoidal rule was used
to calculate the integrated glucose levels over the
course of each 24 hours of insulin infusion. The
integrated responses were divided by 24 hours,
which resulted in a mean daily glucose concentra-
tion. The total daily insulin dose was also divided by
the total daily time interval of insulin infusion to
obtain a mean daily rate. Standard methods were
used to compute means and SEM. Differences
between groups were evaluated using the Student
t test, the Chi-square test, and the Fisher exact test.All statistical tests were 2-tailed. Data are presented
as mean ± SE, and P values < .05 were regarded as
statistically significant.
RESULTS
Study population. The study population con-
sisted of adult patients admitted to the SICU or
BICU and who were treated with the Johns
Hopkins Bayview Medical Center IIT protocol
from October 2006 to July 2007. During this 9-
month interval, 667 patients were admitted to the
10-bed, mixed-service SICU, and 303 patients were
admitted to the 10-bed BICU. Of these 970 pa-
tients, 79 required IIT. Of these 79 patients, 37
remained on the protocol for at least 72 hours, and
comprised our study population. Of the 79 pa-
tients, 22 (60%) were in the SICU and 15 (40%)
were in the BICU. Reasons for failure to continue
in the IIT protocol for at least 72 hours included
cessation of the protocol due to adequate glycemic
control before 72 hours, transfer from ICU to the
surgical floor, or death of the patient. The demo-
graphic data of our study population are presented
in the Table.
Of the 22 patients admitted to the mixed-service
SICU, 5 were surgical patients who had respiratory
complications that included severe asthma, respi-
ratory failure, bronchopneumonia, and bronchitis.
These 22 patients also included 9 with gastrointes-
tinal complications, 3 with oncologic problems, 3
with trauma (admitted for comorbidities), and 2
with infections after orthopedic operations. The
average duration of hospital stay for the SICU
patients was 24 days. Of these 22 patients, 14
(64%) were 65 years of age or older.
The 15 patients admitted to the BICU included
12 patients with thermal injury (average percent-
age of TBSA was 33%; range, 10--80%), 2 with toxic
epidermal necrolysis, and 1 with hip osteomyelitis
secondary to grade 4 pressure ulcers. The average
duration of hospital stay for the 15 BICU patients
was 32 days. Of these 15 patients, 9 (60%) were 65
years of age or older.
Blood glucose control. The average initial blood
glucose level for patients in the SICU was 237 ±
16.1 mg/dL. This value decreased during the 72-
hour study period to a mean glucose level of 162 ±
5.0, 131 ± 3.4, and 143 ± 4.2 mg/dL on days 1, 2,
and 3, respectively. The insulin infusion require-
ments averaged 68 ± 13.8, 134 ± 28.2, and 209 ±
23.5 U on days 1, 2, and 3, respectively (Fig 1).
In the BICU, a similar decrease in mean blood
glucose was observed. The mean admission blood
glucose level was 211 ± 21.5 mg/dL and decreased
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SICU BICU
Tight controlled
#150 mg/dL
Poorly controlled
>150 mg/dL
Tight controlled
#150 mg/dL
Poorly controlled
>150 mg/dL
Number 10 (45%) 12 (56%) 5 (33%) 10 (67%)
Sex
Male 2 6 2 9
Female 8 6 3 1
Age (yr) 64.20 ± 5.55 70.92 ± 2.78 50.6 ± 9.55 54.90 ± 3.94y
BMI (kg/m2) 38.86 ± 5.75 37.17 ± 3.02 26.68 ± 1.16 34.14 ± 2.71
TBSA burn % — — 10.00 ± 2.48 44.75 ± 7.15*
Hypoglycemic events (<60 mg/dL) 0 4 2 1
Length of hospital stay (days) 17.1 ± 5.63 30.25 ± 5.81 18.8 ± 6.87 38.8 ± 9.34
Sepsis 1(10%) 7 (58%) 3 (60%) 7 (70%)
Hospital deaths 0 7 (58%) 1 (20%) 5 (50%)
No significant differences were noted in comparisons of the variables between tight and poorly controlled groups for each ICU. Only age was significantly
different for the poorly controlled groups between the two ICUs (P = .003).
*P # .005 compared to ‘‘tightly’’ controlled in the same ICU.
yP # .003 compared to ‘‘poorly’’ controlled between the 2 ICUs. The number in () represents %.during the 72-hour study period to a mean glucose
level of 161 ± 7.6, 149 ± 4.6, and 153 ± 6.1 mg/dL
on days 1, 2, and 3, respectively. Insulin infusion
requirements were less in this group compared to
the SICU patients, averaging 51 ± 11.7, 97 ± 13.6,
and 110 ± 20.9 U on days 1, 2, and 3, respectively
(P = .005 vs SICU for day 3; Fig 1).
To assess the effect of tight glycemic control on
clinical outcome, SICU and BICU data were di-
chotomized by level of glycemic control. Patients
in both units with a mean blood glucose level#150
mg/dL on day 3 were considered to have achieved
tight control, whereas patients whose average
blood glucose level was >150 mg/dL were consid-
ered poorly controlled. The value of 150 mg/dL
was chosen because it has been used in previous
studies15,16 and approximated the mean day 3 glu-
cose values in the study population.
Of the 22 patients admitted to the SICU, 10
(45%) achieved tight control (glucose level <150
mg/dL) by day 3 on the insulin infusion protocol
(Table). Age and body mass index (BMI), which are
2 variables shown to influence insulin sensitivity and
glucose kinetics, were similar in both the tightly con-
trolled and poorly controlled groups. The mean to-
tal daily insulin for the tightly controlled group was
51 ± 11.6, 94 ± 21.5, and172 ±16.4Uondays 1, 2, and
3, respectively. Interestingly, we noticed that the
poorly controlled group received more insulin
over their 3-day course: 89 ± 26.2, 182 ± 54.2, and
220 ± 33.3 U. The poorly controlled group also
had 4 hypoglycemic (<60 mg/dL) events, suggest-
ing more difficulty with the degree of control.None of the hypoglycemic events noted in this study
were accompanied by any medical sequelae.
In the BICU, only 33% of patients achieved
tight control by day 3 (Table). The tightly con-
trolled group had a greater number of female pa-
tients than the poorly controlled group, similar
to the trend seen in the SICU; age and BMI were
also similar. The mean daily insulin requirement
for the tightly controlled group was 67 ± 13.7,
109 ± 16.9, and 110 ± 23.5 U on days 1, 2, and 3,
respectively. The poorly controlled group had a
lesser mean insulin infusion: 17 ± 9.4, 73 ± 17.9,
111 ± 43.1 U on days 1, 2, and 3, respectively, sug-
gesting insufficient insulin delivery in this group.
A possible reason for a low daily insulin
demand in the BICU patients is that our IIT
protocol requires insulin infusion to be stopped
when feedings are held. Insulin infusion was also
temporarily stopped whenever a patient returned
to the operating room (OR) for grafting, wound
care procedures, etc. As a result, the burn
patient who required frequent trips to the OR
for their burn care or more extensive operative
procedures was at risk for prolonged periods of
cessation of the insulin infusion, with resulting
hyperglycemia. The average duration of time
the insulin infusion protocol was held over the
72-hour study interval in BICU patient was 3.6
hours. The poorly controlled patient group had
insulin held for 4.4 ± 0.51 hours, which was sig-
nificantly greater than the 2.6 ± 0.24 hours for
those patients who achieved tight glycemic con-
trol (P = .022). Other reasons for the decreased
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patients admitted to the surgical intensive care unit (SICU) (left panels) and the burn ICU (BICU) (right panels).insulin demand may have included the relatively
younger age and lower BMI seen in BICU pa-
tients compared to SICU patients (Table).
Sepsis and mortality. There was no mortality in
either unit during the 72 hours of IIT. Overall, of
the 37 patients, 18 (49%) had at least 1 septic
episode. In the SICU, 8 patients were diagnosed
with sepsis, which represented 10% of the tightly
controlled group and 58% of the poorly controlled
group (P < .05). Within the poorly controlled SICU
group, all 7 SICU patients with poor glycemic con-
trol who had septic episodes ultimately died. None
of the patients were septic within the study period
of 72 hours after initial insulin infusion, but be-
came septic subsequently in their hospital course.
In the BICU, septic episodes occurred in 3 of 5
patients with tight glycemic control; 2 of the septic
episodes occurred during the initial 72 hours of
the IIT protocol. One patient had osteomyelitis
and was diagnosed with sepsis within the first 24
hours of insulin therapy. The other patient, who
had a 13% TBSA severe upper body burn, became
septic after 48 hours and ultimately died while in
the BICU.
A total of 7 patients (70%) in the poorly
controlled burn injury group developed sepsis.
Of these 7 patients, 5 ultimately died due to septic
complications; none of these 5 patients had a
septic episode within the first 72 hours of initiating
the IIT protocol.TBSA burn. Patients who achieved tight glyce-
mic control by day 3 had a mean value of TBSA
burn of 10% ± 2.5% (including 1 patient who was
in the BICU with extensive decubitus ulcers and
osteomyelitis, and 2 patients with toxic epidermal
necrolysis). Of the 8 thermally injured patients, 2
had burns >60% TBSA (65% and 75%). These 2
patients averaged a greater time in the OR com-
pared to the other BICU patients and, as such, had
more time with their insulin infusion suspended as
per the IIT protocol. Both patients ultimately died
of septic complications.
Age and mortality. The relationship of tightly
and poorly controlled glucose levels with regard to
sepsis and mortality as a function of age is
presented in Fig 2. Of the 37 patients in our study
population, 15 (41%) were tightly controlled and
22 (59%) were poorly controlled. A total of 19
(51%) were 65 years of age or older, of whom 13
(68%) were poorly controlled. Of the 13 poorly
controlled elderly patients, 8 (62%) died, whereas
no death occurred in the 6 elderly patients with
tightly controlled glucose levels (P = .014).
Of the 18 patients in the younger group (<65
years of age), 9 patients were poorly controlled; 4
of these 9 patients (44%) died, 3 of whom were
BICU patients with sepsis. The 1 death in the
subset of poorly controlled SICU patients less than
65 years old also was due to sepsis. In the group of
9 younger SICU patients with tightly controlled
Surgery
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had sepsis (P = 0.35 vs the younger poorly con-
trolled group).
DISCUSSION
During the stress of critical illness, endogenous
catecholamines, glucocorticoids, glucagon, and
cytokine levels are all increased.9,17 Despite normal
insulin levels, the increase in stress hormones cre-
ates a state of insulin resistance by decreasing insu-
lin receptor binding and activation, as well as the
availability of glucose transporters.18 Elevated glu-
cagon and catecholamine levels stimulate hepatic
glucose production. In addition, patients receive
medications (eg, catecholamines) and nutritional
support, which also increase blood glucose levels.
All of these factors contribute to the development
of a hyperglycemic state. Restoration of euglycemia
has been shown repeatedly to reduce the inci-
dence of hospital-acquired infection and sepsis
and to increase survival in critically ill and injured
patients.1,2,15,16
The patients in our study with a mean blood
glucose #150 mg/dL by day 3 were considered
tightly controlled, and these patients had lower
hospital death rates in both the BICU (20% vs 50%
in the poorly controlled group) and the SICU (0%
vs 58% in the poorly controlled group). With
regard to sepsis, there was a striking difference in
the number of septic events in the SICU between
the 2 glycemic groups (10% in the tightly con-
trolled group and 58% in the poorly controlled
group). The difference in the number of septic
episodes between tightly controlled patients (60%)
Fig 2. Scatterplot of third-day average glucose level as a
function of age and glycemic control with regard to fol-
low-up outcome of sepsis and mortality.compared to poorly controlled patients (70%) in
the BICU was less than the difference observed
between the same group of patients in the SICU
setting.
The failure to confirm a direct association
between sepsis and death in the BICU as opposed
to the SICU may be due to the relatively small
number of patients in our study, as well as the
greater incidence of septic episodes in all the
BICU patients. Nonetheless, survival in the BICU
was clearly associated with tight glycemic control,
as well as with lower TBSA burn percentage and
younger age.
There were a total of 7 hypoglycemic events for
all patients included in this study. Interestingly, 6
of these events occurred in the poorly controlled
(glucose level >150 mg/dL) groups. This finding is
somewhat counterintuitive, because this group has,
by definition, a greater mean blood glucose value.
Episodes of hypoglycemia were routinely treated
with cessation of the insulin infusion and admin-
istration of 50% IV glucose infusion. This practice
invariably resulted in a rebound hyperglycemia
that, in turn, required greater amounts of IV
insulin infusion to control. Therefore, our proto-
col for hypoglycemia treatment required modifica-
tion to prevent overcorrection with both IV
glucose and insulin. Such revisions to the IIT
protocol were made prospectively; as a result, the
incidence of hypoglycemic events was greater
within the first 5 months (N = 5) of the study
period compared to the final 4 months (N = 2).
In an observational retrospective study of 108
trauma patients who had an ICU stay >48 hours,
Gale et al19 found a trend toward a greater mortal-
ity rate in patients with a mean 48-hour blood glu-
cose level >140 mg/dL compared to patients with a
mean glucose level <140 mg/dL (22% vs 9%). In a
medical ICU, Lacherade et al20 found that, in 105
patients who had a medical ICU stay >24 hours,
poor control (defined by an average blood glucose
level >130 mg/dL) was associated with a 50% mor-
tality compared to 22% for those patients who had
values #130 mg/dL. Furthermore, they found that
the odds ratio of ICU death in patients whose
blood glucose was not controlled compared with
patients whose blood glucose was controlled was
>3 independent of other variables. Lacherade
et al20 concluded that the greater mortality rate
may be directly related to failure to maintain glu-
cose control over time and that tighter glucose
control may decrease mortality. These studies
corroborated the report of Scalea et al,16 in which
a similar result was seen in a large trauma
population.
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possibility that hyperglycemia is a result of co-
morbidities and infectious processes rather than a
direct contributor to mortality. In other words,
did hyperglycemia occur as a consequence of
infection/morbidity, or was hyperglycemia a risk
factor for acquiring infection? A post hoc analysis
of Van den Berghe et al’s 2001 study1 revealed a
linear correlation between the degree of hypergly-
cemia and the risk of death; in a 2003 study,21
Van den Berghe et al demonstrated that this cor-
relation persisted after correction for insulin dose
and severity of illness. Multivariate logistic regres-
sion analysis of these data confirmed the inde-
pendent role of blood glucose control in
achieving most of the clinical benefits of IIT
and highlights the importance of lowering blood
glucose levels.
Although our study did not have sufficient
enrollment to support a meaningful multivariate
analysis, a similar argument regarding hyperglyce-
mia as a consequence or as a risk factor of sepsis
may be made by analysis of the temporal sequence
of events. For both the SICU and the BICU
population under study, none of the patients who
became septic and had poor glycemic control were
septic within the IIT study period of 72 hours.
Rather, all septic episodes occurred subsequently
in the patients’ hospital course. Although not
definitive, it would be hard to argue that poor
glycemic control was a result of sepsis that oc-
curred 72 hours after the event.
In the landmark, randomized, prospective trial
of Van den Berghe et al,1 intention to treat with
IIT was clearly associated with reduced septic com-
plications and reduced mortality. This trial and
other prospective trials demonstrate that mainte-
nance of tight glycemic control by IIT has a signif-
icant benefit. This finding raises the possibility that
insulin administration has a beneficial effect that
might be due to metabolic or antiinfectious pro-
cesses independent of glycemic control. Our study
design attempts to control for these factors by ex-
amining only the patients treated with IIT to deter-
mine if the glycemic level achieved--despite IV
insulin administration--correlates with improved sur-
vival. Our findings demonstrate that tight glycemic
control in the ICU is predictive of survival. To our
knowledge, our results also demonstrate for the
first time that this benefit extends to the BICU as
well as the SICU population.
However, it should be noted that studies using
IIT protocols that nearly achieve tight glucose level
at a concentration #110 mg/dL have also re-
ported increased mortality compared to aconventional controlled group in which blood
glucose levels were targeted at concentrations
#180 mg/dL.22 This finding may be due to an ap-
proximate 13-fold increase in the incidence of hy-
poglycemic events in the former group.6
After a major burn injury, there is a hypermet-
abolic response that increases glucose consump-
tion, glycogenolysis, and proteolysis.23 Burn injury
demands an extremely high metabolic response,
with energy requirements met by protein and
amino acid recruitment.24 Severely burned pa-
tients have elevated glucose production and glu-
cose utilization almost entirely through anaerobic
mechanisms.24,25 At the cellular level, the hypergly-
cemic state creates additional oxidative stress and
acts with other mediators to activate inflammation.
Because insulin has been found to have antiinflam-
matory properties, the effects of hyperglycemia can
be exacerbated by the relative insulin resistance
caused by the metabolic component of the stress
response. Reducing stress hyperglycemia has there-
fore become an important clinical and research
topic, with the goal of improving outcomes in crit-
ically ill patients.
TBSA burn is a variable that is unique to the
adult burn patient and is known to be associated
with decreased patient survival. Our BICU popu-
lation in whom we achieved tight control had a
lower mean percentage of TBSA compared to the
poorly controlled group (10% vs 45%). The asso-
ciation between poor glycemic control, sepsis, and
severely burned patients may be related to a
hyperglycemia--induced impairment in antimicro-
bial defense.11 Hyperglycemia has been shown to
retard wound healing in patients with diabetes
mellitus26; therefore, diabetic burn victims could
be expected to have a greater healing time, espe-
cially if the burn wound has a greater percentage
of TBSA. Indeed, the poorly controlled burn vic-
tims had a longer hospital duration of stay.
There are some studies that report counterin-
tuitive findings. In a study by Wahl et al,27 hypergly-
cemia was associated with increased mortality in
the SICU, although no association was observed
between hyperglycemia and infection. In another
study, BICU patients did not benefit from IIT
with respect to mortality or ICU duration of stay,
but hyperglycemia was associated with increased
risk of infection.28
Two patients in our BICU group had a diagnosis
of toxic epidermal necrolysis syndrome (TENS), a
condition causing generalized epidermal necrosis,
erosions of the mucous membranes, and extensive
detachment of the epidermis, accompanied by
severe constitutional symptoms.29 Patients with
Surgery
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ceive care that is identical to that provided to burn
victims including: protection of eroded surfaces,
infection control, nutritional support, and control
of fluids and electrolytes.30 TENS patients are man-
aged in a manner that is similar to thermally in-
jured patients, with surface area necrolysis being
regarded as equal to large TBSA with deep burns.
Care of these patients is focused on support and
early excision and grafting of the involved skin.
Of the 2 patients diagnosed with TENS in our
study, both had glycemic levels that were poorly
controlled, and 1 died from multiple organ failure
due to the progression of sepsis.
The effect of age on the outcome of critically ill
SICU and burn patients has been poorly studied.
Of the 13 deaths in our study, 8 (62%) were in
patients who were $65 years of age. A total of 64%
of the SICU study population and 33% of the
BICU population were $65 years of age. Whereas
the mortality rate for patients <65 years of age was
28%, the rate for those patients >65 years of age
was 42% (43% in the SICU group, 44% in the
BICU group). Although our study was not suffi-
ciently powered to address the issue of age as a
separate variable, we observed that the morbidity
and mortality associated with poor glycemic con-
trol was dramatically greater in both SICU and
BICU elderly patients. In patients 65 years of age
or older whose glycemic level was poorly con-
trolled, the rate of mortality was 62% (Fig 2),
whereas elderly patients who achieved tight glyce-
mic control had 0 mortality.
Rellos et al31 demonstrated that the high inci-
dence of ICU-acquired infections ($70%) appears
to contribute to the greater mortality rate in
elderly ICU patients. In addition, several reports
have confirmed greater ICU mortality in the
elderly.32-36 Unfortunately, all of these studies
evaluated mortality as a function of comorbidities
(eg, cardiac disease, diabetes mellitus, chronic
obstructive pulmonary disease, dementia, stroke,
chronic renal and hepatic insufficiency, and/or
peripheral vascular diseases) but not glycemic con-
trol. In a study of 2064 ICU admissions, the inci-
dence of infection in the SICU was 42%; when
the patients were stratified by age group (<50
years, and each decade thereafter), elderly patients
were not more susceptible to infections than the
younger aged groups.37 However, age was a strong
predictor of mortality in patients with sepsis, and
the death rate increased with each increasing
decade (odds ratio, 1.38--21.9). Our data are con-
sistent with these observations, and it can be
inferred that tightly controlled glycemia in theelderly ICU patient will be especially effective in re-
ducing the incidence of sepsis and death in this
subset of patients.
There are some limitations to our study. First,
only a small population of patients was analyzed in
this study. Second, although the association of
tight glycemic control by day 3 has been used by
other researchers to predict outcomes,1,15 the opti-
mal interval for achievement of glycemic control
and the duration of maintenance to achieve maxi-
mal survival benefit are both unknown. Finally, al-
though the 150 mg/dL glucose criterion was
convenient for this study and has been used in pre-
vious studies, there is no universally accepted value
to define optimal glycemic control. Levels of rec-
ommended glycemic control range from 110
mg/dL to 180 mg/dL with various populations
and studies.1,7,8,15,38 It remains to be determined
which goal is associated with the maximal benefit
of reduced sepsis and death, balanced against the
risk of hypoglycemia. Nonetheless, our results
strongly support the concept that both SICU and
BICU patients benefit from aggressive manage-
ment of glycemic levels.
In conclusion, from our retrospective cohort
study, we conclude that tight glycemic control is
associated with reduced mortality in both the SICU
(0% vs 58%) and the BICU (20% vs 50%) in
patients on IIT. Patient survival in the BICU is asso-
ciated with tight glycemic control, as well as a lower
percentage of TBSA burn and lesser age. This pre-
liminary study reveals an association between im-
proved management of blood glucose and
beneficial outcomes in adult burn victims, and in-
dicates the need for a larger study to confirm these
findings. In addition, our data suggest that hyper-
glycemia may be especially difficult to control in
both elderly and burn patients, and these patients
therefore may be at higher risk of sepsis and mor-
tality. Further exploration of the benefit of tight
glycemic control in the elderly in both the BICU
and SICU is warranted and essential.
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